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During the ongoing coronavirus disease (COV-ID-19) pandemic, worldwide, >85 million severe 
acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infections had been reported as of January 
7, 2021 (https://covid19.who.int). Although it was 
clear from the beginning of the pandemic that symp-
tomatic transmission of SARS-CoV-2 occurs, pres-
ymptomatic transmission has also been described 
(1–6). Furthermore, transmission from asymptomat-
ic cases was deemed possible on the basis of fi ndings 
that viral load of asymptomatic cases was similar to 
that of symptomatic cases (7). Understanding how 
transmission occurs from asymptomatic cases and 
from symptomatic cases in their presymptomatic 
and symptomatic phase, as well as the frequency of 
transmission, is essential for public health manage-
ment. We assessed asymptomatic, presymptomatic, 
and symptomatic transmission during an outbreak 
investigation of 59 COVID-19 cases by determin-
ing secondary attack rates (SAR) according to the 
respective exposure periods. In addition, we esti-
mated key parameters such as serial interval and 
incubation period.
The Study
On February 29, 2020, a COVID-19 case was notifi ed to 
the local public health authority (LPHA) of a rural dis-
trict in southern Germany without previously observed 
community transmission. During the infectious period, 
the case-patient had attended several carnival events 
in the district. The LPHA immediately initiated contact 
tracing, identifying all close contacts; they were quaran-
tined and tested irrespective of symptoms. By the end 
of March 2020, a cluster of 59 cases had been identifi ed 
through successive contact tracing activities.
We interviewed the case-patients of the clus-
ter by phone regarding symptoms developed dur-
ing SARS-CoV-2 infection; potential source cases 
or events; and household contacts (HCs) and close 
nonhousehold or other contacts (OCs) in their infec-
tious period (Appendix, https://wwwnc.cdc.gov/
EID/article/27/4/20-4576-App1.pdf). We obtained 
an empirical distribution of the serial interval from 
the average over all possible transmission trees of the 
cluster. We obtained generation time and incubation 
period by averaging over the estimates as described 
by Reich et al. (8) (Appendix).
To estimate SAR and relative risks (RRs) we 
conducted a retrospective cohort study, including 
all HCs and OCs as recalled by the case-patients 
that met inclusion criteria (Appendix). We calcu-
lated pooled SAR of HCs and OCs for 2 outcomes, 
laboratory confi rmation (SARlab) and development 
of respiratory symptoms (SARres) in the following 
groups: HCs and OCs of asymptomatic case-patients 
who never experienced symptoms; HCs and OCs of 
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We determined secondary attack rates (SAR) among 
close contacts of 59 asymptomatic and symptomatic 
coronavirus disease case-patients by presymptomatic 
and symptomatic exposure. We observed no transmis-
sion from asymptomatic case-patients and highest SAR 
through presymptomatic exposure. Rapid quarantine of 
close contacts with or without symptoms is needed to pre-
vent presymptomatic transmission.
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symptomatic case-patients in which the phase with 
contact could not be specified by the case-patient or 
with contact in both phases; OCs of symptomatic 
case-patients with contact only in the presymptom-
atic phase; and OCs of symptomatic case-patients 
with contact only in the symptomatic phase.
We were able to contact 53/59 (90%) case-pa-
tients. Three case-patients were children <15 years of 
age (Table 1). Forty-six (87%) were symptomatic, and 
7 (13%) were asymptomatic (Appendix Figure 1). The 
cluster resulted in 144 possible transmission trees, 
which span over 5 generations (Figure). No second-
ary transmission resulted from asymptomatic cases. 
We determined a median serial interval of 3.0 (IQR 
1.0–6.0) days and a median incubation period of 4.3 
(IQR 2.5–6.5) days (Appendix Table 1).
In total, 42 HCs and 212 OCs were included in 
the cohort study (Table 1). The overall SARlab was 13% 
(4/32) for HCs and 14% (20/148) for OCs. The over-
all SARres was 29% (12/42) for HCs and 17% (29/170) 
 




No. (%) symptomatic  
Total 






Case-patients      
 Total 7 (13.2) 46 (86.8) NA NA 53 (100) 
 Female 3 (11.5) 23 (88.5) NA NA 26 (100) 
 Male 4 (14.8) 23 (85.2) NA NA 27 (100) 
 Median age 36 (IQR 6–68) 40 (IQR 29–50) NA NA 39.5 (IQR 29–50)‡ 
Contact persons by type of exposure  
 HC 7 (16.7) 35 (83.3) NA NA 42 (100) 
 OC 52 (24.5) 48 (22.6) 81 (38.2)  31 (14.6) 212 (100) 
*HC, household contact; IQR, interquartile range; NA, not applicable; OC, nonhousehold or other contact. 
†The phase in which the contact occurred was not specified, or contact occurred in both phases. 
‡Three of 53 cases were children <15 y of age. 
 
 
Figure. Transmission tree 
of the investigated cluster 
of coronavirus disease that 
evolved in a district in southern 
Germany. Cases 39, 40, and 
60 participated in the survey 
but were not included in the 
analysis because we had 
no information on source 
case. Cases 7 and 27 did 
not participate in the survey 
and thus, no information on 
source case was available. 
Dashed lines represent source 
case–infectee pairs in which 
the infectee reported >1 
possible source case; solid 
lines represent source case–
infectee pairs in which only 
1 source case was mapped 
to the infectee. Asterisks (*) 
indicate asymptomatic cases. 
Implausible transmissions (e.g., 
ID 6) were omitted.
for OCs (Table 2). We did not identify any HC who 
tested positive or experienced respiratory symptoms 
after contact with asymptomatic case-patients. Nei-
ther SARlab nor SARres of HCs of symptomatic case-
patients were significantly higher compared with 
HCs of asymptomatic cases (SARlab p = 1.0; SARres p 
= 0.23). We observed no laboratory-confirmed SARS-
CoV-2 transmission from asymptomatic case-patients 
to any of the 22 OCs (Table 2; Appendix Figure 2). 
SARlab was highest for OCs with contact during the 
case-patients’ presymptomatic phases (21%; 15/72) 
yielding a RR of 6.5 (95% CI 1.1–∞) when compared 
with contacts of asymptomatic case-patients. Adjust-
ing for case-patients’ age, sex, and number of contact 
persons showed no substantial changes in the magni-
tude of estimates (data not shown). Presymptomatic 
transmission accounted for >75% of all transmissions 
to OCs in the cohort (Appendix).
Conclusions
In this cluster of COVID-19 cases, little to no trans-
mission occurred from asymptomatic case-patients. 
Presymptomatic transmission was more frequent 
than symptomatic transmission. The serial interval 
was short; very short intervals occurred.
The fact that we did not detect any laboratory-con-
firmed SARS-CoV-2 transmission from asymptomatic 
case-patients is in line with multiple studies (9–11). 
However, Oran et al. have speculated that asymptom-
atic cases contribute to the rapid progression of the pan-
demic (12). Some studies may be prone to misclassify 
presymptomatic cases as asymptomatic, leading to 
heterogeneous reporting of SAR of asymptomatic 
cases, because of different case definitions or differ-
ential duration of follow-up. In our study we used a 
very sensitive case definition for symptomatic cases 
that did not require specific symptoms (e.g. fever) to 
be present. Also, timing of our study would have en-
abled detection of late onset of symptoms, which gives 
us confidence in our classification of exposure groups.
The 75% of SARS-CoV-2 transmissions in our 
cohort from case-patients in their presymptomatic 
phase exceeds reported transmission rates from other 
investigations (1,13,14). Possible reasons are the prior 
evidence that infectiousness peaks around the date 
of symptom onset, declining thereafter (15), and that 
case-patients probably reduced social contacts them-
selves once they experienced symptoms or when or-
dered to self-isolate. A large proportion of cases with 
presymptomatic transmission in our cluster is further 
supported by the median serial interval of 3 days.
Of note are the consequences for public health 
management: first, the need for early detection of CO-
VID-19 cases and for initiation of contact tracing as 
soon as possible to quarantine close contacts, particu-
larly because short serial intervals may lead to further 
transmission chains. Second, suspect case-patients or 
persons with any respiratory illness should immedi-
ately self-isolate and inform their contacts met in the 
presymptomatic and symptomatic phases.
A limitation of our study is that evidence was 
obtained from a single outbreak and might not be 
 
Table 2. Secondary attack rates among contacts of coronavirus disease case-patients in a district in southern Germany* 
Clinical symptoms of source case 
No. contacts tested positive or 
experienced respiratory symptoms 
Total no. 
contacts SAR, % RR (95% CI) 
Household contacts SARlab     
 Asymptomatic 0 4 0 Reference 
 Symptomatic, phase not specified or both† 4 28 14.3 0.8 (0.09–∞) 
 Total 4 32 12.5  
Household contacts SARres     
 Asymptomatic 0 7 0 Reference 
 Symptomatic, phase not specified or both 12 35 34.3 3.4 (0.56–∞) 
 Total 12 42 28.6  
Other contacts SARlab     
 Asymptomatic cases 0 22 0 Reference 
 Symptomatic, phase not specified or both 3 25 12.0 3.4 (0.36–∞) 
 Symptomatic, presymptomatic phase only 15 72 20.8 6.5 (1.1–∞) 
 Symptomatic, symptomatic phase only 2 29 6.9 1.8 (0.14–∞) 
Total 20 148 13.5  
Other contacts SARres     
 Asymptomatic cases 2 52 3.8 Reference 
 Symptomatic, phase not specified or both 4 22 18.2 4.7 (0.68–52) 
 Symptomatic, presymptomatic phase only 22 67 32.8 8.5 (2.1–75) 
 Symptomatic, symptomatic phase only 1 29 3.5 0.90 (0.02–17) 
 Total 29 170 17.1  
*RR relative risk; SAR, secondary attack rate; SARlab secondary attack rate for laboratory-confirmed SARS-CoV-2–positive contact persons; SARres, 
secondary attack rate for contact persons who experienced respiratory symptoms after contact.  
†The phase in which the contact occurred was not specified, or contact occurred in both phases. 
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applicable to other settings. We used only infor-
mation as recalled by the case-patients, which is 
imperfect and may introduce errors or bias. Be-
cause we used development of respiratory symp-
toms as a proxy for possible SARS-CoV-2 infec-
tions among contacts, and because incidence of 
respiratory illnesses was still high in this winter 
timeframe, SARres may be overestimated. Howev-
er, this possible source of misclassification should 
be nondifferential between groups. We excluded 
many HCs because of uncertainties about the po-
tential simultaneous introduction of SARS-CoV-2 
in the household, which may have led to an under-
estimation of SAR among HCs. In the transmission 
tree, we had to omit various source case–infectee 
pairs because case-patients’ recalled symptom on-
set differed substantially from surveillance data 
and was not plausible (Appendix). Finally, al-
though community transmission of SARS-CoV-2 
was deemed unlikely in the affected district at the 
time, we cannot rule out that some cases acquired 
infections from other sources.
In conclusion, our study suggests that asymp-
tomatic cases are unlikely to contribute substan-
tially to the spread of SARS-CoV-2. COVID-19 cases 
should be detected and managed early to quarantine 
close contacts immediately and prevent presymp-
tomatic transmissions.
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